OFFSPRING BIRTH WEIGHT AND MATERNAL FASTING LIPIDS IN WOMEN SCREENED FOR GESTATIONAL DIABETES MELLITUS

  • Dr. Janaki Menon C.M Resident, Department of OBG, Father Muller Medical College, Mangalore, Karnataka, India
  • Dr. Nagarathna G Professor of Obstetrics and Gynecology, Father Muller Medical College, Mangalore, Karnataka, India
  • Dr. Sudeep K. Professor, Endocrinology, Father Muller Medical College, Mangalore, Karnataka, India
Keywords: Carcinoma cervix, calvarial metastasis, recurrent

Abstract

Introduction: The most common neonatal complication of gestational DM is macrosomia. During early pregnancy, an accumulation of maternal fat depots occurs followed by increased adipose tissue lipolysis and subsequent hyperlipidemia which mainly corresponds to increased triglycerides in all circulating lipoproteins. In GDM women the enhanced insulin resistance and altered estrogen-progesterone ratio are responsible for the reported wide range of dyslipidemic conditions1. Association of high maternal glucose levels and fetus macrosomia have been documented. The prospective Amsterdam Born children and development cohort study, reported that high maternal TG levels in early pregnancy were associated with higher Birth weights and subsequently a higher occurrence of LGA births, whereas low TG levels were associated with accelerated postnatal growth2. Total cholesterol, HDL and lipoprotein concentrations are not significantly different between GDM patients and control subjects3.

Materials and Methods: It is a prospective observational study done on patients coming to the department of OBG, Father Mullers Hospital, Mangalore for antenatal checkup over the period of one year and nine months. All Antenatal mothers are advised to undergo OGCT test as part of universal screening for GDM according to their convenience. Minimum of 100 Patients with positive OGCT (> 140mg/dl) were selected. Detailed clinical evaluation including relevant history and physical examination was undertaken. They are asked to undergo OGTT test.

Results: Among the total of hundred GCT positive patients studied, 41 patients were GTT positive and 59 were GTT negative. Elevated triglycerides were found in 31(75%) of GTT positive patients. Elevated serum cholesterol levels were seen in 21(51.21%) of GDM mothers. Forty-one (69%) patients in the normal GTT group had elevated triglycerides and 31(52%) among the normal GTT group had elevated cholesterol. Among the 100 patients studied, there were 25 babies with birth weight more than 3.5 kg.

Discussion and Conclusion: Various studies have been conducted in different parts of the world to correlate between maternal glucose levels and macrosomia as well as lipid alterations with fetal weight changes in normoglycemic as well as diabetic patients. Our study was also aimed at finding whether any relationship existed between the development of macrosomia in diabetic or nondiabetic patients and relationship with maternal fasting lipids, mainly serum triglycerides. Our study shows elevated triglycerides and cholesterol both in gestational diabetic patients as well as nondiabetic controls.

Conclusion: Our study did not find any positive correlation between elevated triglycerides and GDM as well as between elevated total serum cholesterol and GDM. Elevated birthweight more than 3500 g also was not significantly found to be associated with either elevated serum triglyceride levels or serum cholesterol levels.

Downloads

Download data is not yet available.

References

[1]Emilio Herrera et al, Disturbances in lipid metabolism in diabetic pregnancy, are these causes of the problem? Best practice and research clinical endocrinology and metabolism 24(2010); 515-525.
[2] Vrijkotte TGM et al, Maternal triglyceride in early pregnancy and association with birth weight and postnatal growth. J Pediatr 2011;159:736-42.
[3] E Koukkou et al, Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a crosssectional and prospective study, J Clin Pathol 1996; 49:634-637.
[4]Schwartz R et al, Hyperinsulinemia and macrosomia in the fetus of a diabetic mother.Daibetes care 1994; 17:640-648
[5] DIAMANT Y. Z, METZGER et al placental glycogen and lipid content in human and experimental diabetes mellitus Am. J. Obstet. Gynecol 144:5-11
[6] James, Steer. High-Risk Pregnancy, 2011; 795-811
[7] American Diabetes Association: Gestational diabetes mellitus.Diabetes Care 27 (Suppl.1): S88-S90,2004
[8] Wood SL, Sauvé RS et al Prediabetes and perinatal mortality. Diabetes Care 23:1752-1754, 2000
[9] CianniGD, Miccoli R et al: intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 19:259-270, 2003
[10] Zeynep Osar ERSANLI et al Lipid metabolism alterations in patients with gestational diabetes mellitus associated fetal macrosomia. Ann.1stsuper.sanita,
vol 33, n.3 (1997) p 411-415
[11] Desoye G, Schweditsch MO et al correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum .J Clin Endocrinol Metab 1987; 64:704-712
[12] Sheffield JS, Butler-Koster EL et al: Maternal diabetes mellitus and infant malformations. Obstet Gynecol100:925-930, 2002
[13] C.L Davis et al history of gestational diabetes, insulin resistance, and coronary risk, J Diabetes complications 13 (1999) 216-223
[14] Tracy L et al Gestational Diabetes Mellitus.Clinical Diabetes: Vol 23, Number 1, 2005
[15]Seshiah V, Balaji V, Madhuri S Balaji, Sanjeevi CB, Green A. Gestational Diabetes Mellitus in India. J Assoc Physic of India2004; 52:707–11.
[16]Nahum GG, Wilson SB, Stanislaw H. Early-pregnancy glucose screening for gestational diabetes mellitus. J Reprod Med 2002; 47:656-62.
[17]DIPSI GUIDELINES JAPI • VOL. 54 • AUGUST 2006
[18]Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30(suppl 2): S251–S260.
[19] American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines
for obstetrician-gynecologists. Number 30, September 2001 Gestational diabetes. Obstet Gynecol. 2001;98(3):525–538.
[20]Langer O, Conway DL et al, a comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343(16):1134-1138
[21]Rowan JA, Hague WM et al MiG Trial Investigators.Metformin versus insulin for the treatment of GDM.N Engl J Med2008;358(19):2003-2015
[22] KALKHOFF R.K 1991 Impact of maternal fuels and nutritional state on fetal growth. Diabetes 40 (suppl.2): 61-65
[23] GRUPPUSO P.A, CURRAN T.R et al 1991 Fetal growth factors as determinants of intrauterine hepatic growth. Diabetes 40 (Suppl.2) :51-55
[24] DIAMANT Y. Z, et al placental glycogen in experimental diabetes mellitus Am. J. Obstet. Gynecol 144:5-11
[25] Casey BM, Lucas MJ et al: Pregnancy outcome in women with gestational diabetes compared with general obstetric population. Obstet Gynecol 1997;90:869-
873
[26] ]Knopp RH, Magee MS et al: lipid metabolism in pregnancy, in Cowett RM, Principles of perinatal-neonatal metabolism. newyork, Springer Verlag, 1991, pp 177-203
[27]Warth MR, Knopp RH et al: Lipid metabolism in pregnancy, interactions of diabetes, body weight, age and diet Diabetes 26:1056-1062,1977
[28]Herrera E et al Placental transport of free fatty acids, glycerol and ketone bodies fetal and neonatal physiology vol 1, Philadelphia, 1992, pp 291-298
[29] Mc Gladdery SH et al lipoprotein lipase and apoEpolymorphisms: relationship to hypertriglyceridemia during pregnancy. J Lipid Res 2001 Nov;42 (11):1905-12
[30] Herrera E and Lasuncion M A.Maternal –fetal transfer of lipid metabolites. In Polin RA Fetal and neonatal physiology Philadelphia: Saunders,2004 pp 375-388
[31] ] Merzouk H Bouchenak M et al fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations
and compositions. Clin Pathol 2000; 53:917-923
[32] ] Mantzoros .CS et al insulin resistance, the clinical spectrum. Advances in endocrinology and metabolism 1995;6:193-232
[33] Marseille Tremblay C et al Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol
Reprod Dev 2008;75:1054-1062
[34] Metzger BE, Phelps RL et al.Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids.Diabetes care 1980;3:402-9
[35] Hollingworth DR, Grundy SM Pregnancy-associated triglyceridemia in normal and diabetic women .Diabetes 1982;31:1092-7
[36] S C Couch, E H Philipson et al Maternal and cord plasma lipid and lipoprotein concentrations in women with or without gestational diabetes mellitus:
predictors of birth weight J. Reprod Med 43 (1998) 816-822.
[37] Montelongo A, Lasuncion MA et al: longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes
41:1651-1659,1992
[38] Knopp RH, Xiao-Dong et al: Role of plasma lipoproteins and hormones during diabetic pregnancy. Clin Diabetes may/June 76-77, 1994
[39] Howard B V Lipoprotein metabolism in diabetes mellitus. J Lipid Res1987; 28:613-28
[40] ] Schaefer Graf UM et al, maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus
Diabetes care 2008;31:1858-1863
[41] Knopp et al, Diabetes care 1980;3:416- 20.
[42] Leila Sekhavat et al, Maternal serum triglyceride at midpregnancy and newborn weight in nondiabetic and normal BMI women, NJOG 2008 May June; 3(1): 19-23.
[43] Piyush Gupta, Growth and development, Textbook of Pediatrics, 2nd edition.
[44] Kathy white, Hannah Kelly, Vicky O’ Dwyer, Michelle Gibbs, Amy O’Higgins, Michael J. Turner; Offspring birth weight and maternal fasting lipids in women
screened for GDM; European journal of obstetrics and gynecology 2013;8077.
[45]Hyon Son et al, Maternal serum triglycerides as predictive factors for large for gestational age newborns with gestational diabetes mellitus. Acta Obstet
Gynecol 2010; 89:700-4
How to Cite
1.
Dr. Janaki Menon C.M, Dr. Nagarathna G, Dr. Sudeep K. OFFSPRING BIRTH WEIGHT AND MATERNAL FASTING LIPIDS IN WOMEN SCREENED FOR GESTATIONAL DIABETES MELLITUS. Med. res. chronicles [Internet]. 2018Apr.30 [cited 2024Dec.22];5(2):110-25. Available from: https://medrech.com/index.php/medrech/article/view/295
Section
Original Research Article